No evidence of tumor growth stimulation in human tumors in vitro following treatment with recombinant human growth hormone

Anti-Cancer Drugs

Volumn 11, Issue 8, 2000, Pages 659-664

  Fiebig, H H ^a,c   Dengler, W ^a   Hendriks, H R ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Hendriks Pharmaceutical Consulting   (Netherlands)

^c Institute of Experimental Oncology   (Germany)

Author keywords

Clonogenic assay; Human tumor xenografts; In vitro; Recombinant human growth hormone

Indexed keywords

HUMAN GROWTH HORMONE;

ARTICLE; BREAST CANCER; CACHEXIA; CANCER GRAFT; CANCER INHIBITION; CLONOGENIC ASSAY; COLORECTAL CANCER; CONTROLLED STUDY; GROWTH STIMULATION; HUMAN; HUMAN CELL; KIDNEY CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MOUSE; NUDE MOUSE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; TUMOR GROWTH;

ANIMALS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; MICE; MICE, NUDE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0033787868     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200009000-00011     Document Type: Article

References (40)

1. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group
2. Biology of cachexia
3. Cachexia bij kanker: Stoornisen in de eiwit- en aminozuurstofwisseling
4. Pharmacologic management of anorexia/cachexia
5. Human growth hormone is able to reduce tumour-induced cachexia in a human tumour xenograft model without tumour stimulation
6. Growth hormone administration reduces urea nitrogen loss in malnourished cancer patients
7. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation
8. Growth hormone in surgery - Current knowledge
9. Immunological and endocrinological response to growth hormone therapy in short children
10. Effects of growth hormone and insulin-like growth factor I and T- and B-lymphocytes and immune function
11. Growth hormone inhibits tumor metastasis
12. Growth hormone, insulin, and somatostatin therapy of cancer cachexia
13. Metastatic behavior of the RIF-1 murine fibrosarcoma: Inhibited by hypophysectomy and partially restored by growth hormone replacement
14. Impact of exogenous growth hormone on host preservation and tumor-cycle distribution in a rat sarcoma model
15. Growth hormone and tumor recurrence
16. Establishment and characterization of human tumor xenografts in thymus-aplastic nude mice
17. Combined in vitro/in vivo test procedure with human tumor xenografts
18. Comparison of tumor response in nude mice and in patients
19. Correlation of drug response in patients and in the clonogenic assay with solid human tumor xenografts
20. The clonogenic assay with human tumour xenografts: Evaluation, predictive value and application for drug screening
21. Primary bioassy of human tumor stem cells
22. Improved detection of drug cytotoxicity in the soft agar colony formation assay through use of a metabolizable tetrazolium salt
23. Metabolic and endocrine alterations in osteosarcoma patients
24. Stimulatory effects of growth hormone on rat bladder carcinogenesis
25. Myelodysplastic syndrome during recombinant human growth hormone supplementation after treatment for neuroblastoma
26. Growth hormone treatment and development of malignancy: Recombinant human growth hormone does not induce leukemia in AKR/O-mice
27. Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience
28. Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan
29. Growth hormone administration after treatment in the resistant hepatocyte model does not affect progression of rat liver carcinogenesis
30. Acute leukemias express a functional receptor for the human growth hormone
31. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure
32. Cytokine levels (IL-6 and IFN-γ), acute phase response and nutritional status as prognostic factors in lung cancer
33. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults
34. Growth hormone dose regimens in adult GH deficiency: Effects on biochemical growth markers and metabolic parameters
35. The in vitro and in vivo effects of human growth hormone administration on tumor growth of rats bearing a transplantable rat pituitary tumor (7315b)
36. Effect of human growth hormone on human pancreatic carcinoma growth, protein, and cell cycle kinetics
37. Growth hormone and experimental cancer cachexia
38. Growth hormone administration preserves lean body mass in sarcoma-bearing rats treated with doxorubicin
39. Effect of growth hormone on tumor and host in an animal model
40. In vivo cytokinetic effects of recombinant human growth hormone (rhGH) in patients with advanced breast carcinoma